Effects of Zinc in the treatment of patients with pulmonary tuberculosis
Not Applicable
Recruiting
- Conditions
- Pulmonary tuberculosis.Respiratory tuberculosis, bacteriologically and histologically confirmed
- Registration Number
- IRCT2016110630729N1
- Lead Sponsor
- Zabol University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
All tuberculosis diagnosed patients with the age ranged between 10-60 years. Exclusion criteria: Any chromosomal disorders; allergy to zinc; chronic renal disease; any other supplement or placebo assumption; side effect appearance such as blurred vision, pulmonary edema, icter and severe gastrointestinal symptoms.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sputum smear. Timepoint: Beginning of diagnosis and two months, four months and six months after diagnosis. Method of measurement: Sputum smear.
- Secondary Outcome Measures
Name Time Method Serum zinc level. Timepoint: Beginning of diagnosis and two months, four months and six months after diagnosis. Method of measurement: Serum zinc level in micrograms per liter.